S&P 500   4,288.39
DOW   33,433.35
QQQ   361.26
Nvidia Stock, Christmas Comes Early If You’re On the Fence
Is Gold Really Boring? (Ad)
Here’s Why Cloudflare may be the Ultimate Cloud Stock to Own
3 Drone Stocks That Can Lift Your Portfolio Higher
Is Gold Really Boring? (Ad)
Fed's Powell gets an earful about inflation and interest rates from small businesses
3 Quality Stocks On Track for Significant Dividend Increases
Is Gold Really Boring? (Ad)
5 Reasons Why Arcos Dorados Is A Perfect Investment for 2024
These Great-Grandparents Booked 51 Back-to-Back Cruises Because It's 'Cheaper Than a Retirement Home'
S&P 500   4,288.39
DOW   33,433.35
QQQ   361.26
Nvidia Stock, Christmas Comes Early If You’re On the Fence
Is Gold Really Boring? (Ad)
Here’s Why Cloudflare may be the Ultimate Cloud Stock to Own
3 Drone Stocks That Can Lift Your Portfolio Higher
Is Gold Really Boring? (Ad)
Fed's Powell gets an earful about inflation and interest rates from small businesses
3 Quality Stocks On Track for Significant Dividend Increases
Is Gold Really Boring? (Ad)
5 Reasons Why Arcos Dorados Is A Perfect Investment for 2024
These Great-Grandparents Booked 51 Back-to-Back Cruises Because It's 'Cheaper Than a Retirement Home'
S&P 500   4,288.39
DOW   33,433.35
QQQ   361.26
Nvidia Stock, Christmas Comes Early If You’re On the Fence
Is Gold Really Boring? (Ad)
Here’s Why Cloudflare may be the Ultimate Cloud Stock to Own
3 Drone Stocks That Can Lift Your Portfolio Higher
Is Gold Really Boring? (Ad)
Fed's Powell gets an earful about inflation and interest rates from small businesses
3 Quality Stocks On Track for Significant Dividend Increases
Is Gold Really Boring? (Ad)
5 Reasons Why Arcos Dorados Is A Perfect Investment for 2024
These Great-Grandparents Booked 51 Back-to-Back Cruises Because It's 'Cheaper Than a Retirement Home'
S&P 500   4,288.39
DOW   33,433.35
QQQ   361.26
Nvidia Stock, Christmas Comes Early If You’re On the Fence
Is Gold Really Boring? (Ad)
Here’s Why Cloudflare may be the Ultimate Cloud Stock to Own
3 Drone Stocks That Can Lift Your Portfolio Higher
Is Gold Really Boring? (Ad)
Fed's Powell gets an earful about inflation and interest rates from small businesses
3 Quality Stocks On Track for Significant Dividend Increases
Is Gold Really Boring? (Ad)
5 Reasons Why Arcos Dorados Is A Perfect Investment for 2024
These Great-Grandparents Booked 51 Back-to-Back Cruises Because It's 'Cheaper Than a Retirement Home'
NASDAQ:PRPO

Precipio (PRPO) Stock Forecast, Price & News

$5.74
+0.13 (+2.32%)
(As of 10/2/2023 ET)
Compare
Today's Range
$5.61
$5.87
50-Day Range
$5.30
$112.00
52-Week Range
$4.75
$20.48
Volume
4,823 shs
Average Volume
26,557 shs
Market Capitalization
$7.92 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$40.00

Precipio MarketRank™ Forecast

Analyst Rating
0.00 Rating Score
Upside/​Downside
596.9% Upside
$40.00 Price Target
Short Interest
Healthy
1.07% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.07mentions of Precipio in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.64 out of 5 stars


PRPO stock logo

About Precipio (NASDAQ:PRPO) Stock

Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; and COVID-19 antibody tests. It sells ICE- technology kits to bio-pharma customers. The company is based in New Haven, Connecticut.

PRPO Price History

PRPO Stock News Headlines

Precipio Continues to Sign New HemeScreen™ Customers
Is Gold Really Boring?
Many investors perceive gold as a "boring" investment. But according to MoneyWeek, that's a good thing. Gold helps investors sleep soundly as it preserves wealth and creates a hedge against inflation. Today, there's a unique way to invest in gold, with real advantages over coins and mining stocks.
The "Plug and Play" Model Putting Online Giants to Shame
While e-commerce has been undergoing a turbulent time, a "simple" model has grown 4X faster than Amazon over the last 3 years. Applying this model to high-margin, recession-resistant businesses has shown to be profitable. But that's just the beginning of explaining the 400+% growth - and potential - of this "diamond in the rough."
Precipio's Earnings: A Preview
Precipio Announces Q2-2023 Shareholder Update Call
Precipio Shares Growth Catalysts For HemeScreen
Precipio Announces Q1-2023 Shareholder Update Call
Precipio Signs Another HemeScreen™ Customer
See More Headlines
Receive PRPO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Precipio and its competitors with MarketBeat's FREE daily newsletter.

PRPO Company Calendar

Last Earnings
8/11/2023
Today
10/03/2023
Next Earnings (Estimated)
11/09/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Analytical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:PRPO
Employees
53
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$40.00
High Stock Price Forecast
$40.00
Low Stock Price Forecast
$40.00
Forecasted Upside/Downside
+596.9%
Consensus Rating
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

Net Income
$-12,200,000.00
Pretax Margin
-98.38%

Debt

Sales & Book Value

Annual Sales
$9.41 million
Book Value
$14.34 per share

Miscellaneous

Free Float
1,232,000
Market Cap
$7.92 million
Optionable
Not Optionable
Beta
2.04
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

  • Mr. Ilan DanieliMr. Ilan Danieli (Age 51)
    Founder, Pres, CEO & Director
    Comp: $324.1k
  • Dr. Ayman A. Mohamed M.D. (Age 38)
    Chief Technology Officer
    Comp: $234.1k
  • Mr. Matthew Gage (Age 56)
    Interim Chief Financial Officer
  • Mr. Ahmed Zaki SabetMr. Ahmed Zaki Sabet (Age 36)
    Chief Operating Officer
  • Ms. Miri Chiko-Radomski
    Chief Legal Counsel & People Officer













PRPO Stock - Frequently Asked Questions

What is Precipio's stock price forecast for 2023?

0 brokers have issued 1 year price objectives for Precipio's shares. Their PRPO share price forecasts range from $40.00 to $40.00. On average, they anticipate the company's stock price to reach $40.00 in the next year. This suggests a possible upside of 596.9% from the stock's current price.
View analysts price targets for PRPO
or view top-rated stocks among Wall Street analysts.

How have PRPO shares performed in 2023?

Precipio's stock was trading at $11.0280 at the beginning of the year. Since then, PRPO shares have decreased by 48.0% and is now trading at $5.74.
View the best growth stocks for 2023 here
.

When is Precipio's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 9th 2023.
View our PRPO earnings forecast
.

How were Precipio's earnings last quarter?

Precipio, Inc. (NASDAQ:PRPO) announced its quarterly earnings data on Friday, August, 11th. The biotechnology company reported ($1.80) EPS for the quarter. The biotechnology company had revenue of $3.53 million for the quarter. Precipio had a negative trailing twelve-month return on equity of 68.54% and a negative net margin of 98.50%.

When did Precipio's stock split?

Shares of Precipio reverse split on Friday, September 22nd 2023. The 1-20 reverse split was announced on Friday, September 22nd 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, September 22nd 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

What other stocks do shareholders of Precipio own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Precipio investors own include Biocept (BIOC), Heat Biologics (HTBX), Portola Pharmaceuticals (PTLA), iBio (IBIO), Inovio Pharmaceuticals (INO), T2 Biosystems (TTOO), VBI Vaccines (VBIV), Co-Diagnostics (CODX), Inpixon (INPX) and Jaguar Health (JAGX).

What is Precipio's stock symbol?

Precipio trades on the NASDAQ under the ticker symbol "PRPO."

How do I buy shares of Precipio?

Shares of PRPO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Precipio's stock price today?

One share of PRPO stock can currently be purchased for approximately $5.74.

How much money does Precipio make?

Precipio (NASDAQ:PRPO) has a market capitalization of $7.92 million and generates $9.41 million in revenue each year.

How can I contact Precipio?

Precipio's mailing address is 4 Science Park, New Haven CT, 06511. The official website for the company is www.precipiodx.com. The biotechnology company can be reached via phone at (203) 787-7888, via email at investors@precipiodx.com, or via fax at 402-452-5401.

This page (NASDAQ:PRPO) was last updated on 10/3/2023 by MarketBeat.com Staff

My Account -